Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹-1.01% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
Rating
3
Minimum Investment
₹1000
NAV (Net Asset Value)
₹N/A
AUM (Fund size)
₹1103 Cr
Created on
3 July 2019
Fund Ranking
#13
/ 17 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
6 Month
17.9%
1 Year
14.9%
3 Year (CAGR)
18.8%
All Time (CAGR)
19.0%
Category Return
6 Month
18.4%
1 Year
13.5%
3 Year (CAGR)
20.1%
All Time (CAGR)
16.9%
Asset Allocation
Equity
96.4%
Other
3.6%
Top 5 Holdings
Top 5 Sectors
Apollo Hospitals Enterprise
6.85%
Aurobindo Pharma
4.53%
Cipla
5.16%
Dr. Reddy's Laboratories
1.04%
Ipca Laboratories
2.71%
Fund Information
Expense Ratio
2.29%
Exit Load
Exit load of 1% if redeemed within 30 days.
Lock-In Period
No Lock-In
Managed By
Dhaval Shah
June 2019 - Present
Dhaval Joshi
Nov 2022 - Present
Risk & Return Ratio
Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance.
0.82
Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment.
15.55
Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance.
-1.06
Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility.